Novo Nordisk adds four registrations: new molecule trial, CagriSema switch study, real-world dataSep 30Weekly roundup, 7 itemsCagrisemaNNC0705-0002Updated
Novo Nordisk registers Phase 3 cagrilintide trial; Penn semaglutide study posts resultsAug 4Weekly roundup, 2 itemscagrilintideNovo Nordisk A/S
Sign inSign in